Axtria™ Inc. announces a strategic agreement to improve productivity & effectiveness through incentives and bonuses for all global commercial teams on the cloud-based Axtria SalesIQ™ platform.

    Axtria, a global big data analytics company, is pleased to announce a strategic agreement with Boehringer Ingelheim (a top 20 pharmaceutical manufacturer) to provide end-to-end Incentive Compensation services to its global commercial teams. As part of the agreement, over 12,000 users across Boehringer Ingelheim’s global markets will be deployed on Axtria’s SalesIQ. There are already 3,500 users in the US and Japan live on the platform today.

    Previously, all bonus and incentive processes at Boehringer Ingelheim were localized within each business unit and region. With a focus on driving field force effectiveness, Boehringer Ingelheim aims to standardize on a modern, enterprise-grade platform that aligns compensation strategies and implements best practices globally.

    “Axtria proved that they not only have a strong platform and experience to deploy in an agile way a state of the art bonuses and incentives platform but also proved they have a strong global experience on how to bring to the next level Customer Facing Roles motivation through bonuses and incentives therefore impacting their productivity and effectiveness.” said Dave Arnold, Head of Customer Engagement Excellence at Boehringer Ingelheim.

    Axtria SalesIQ is an integrated, cloud based sales planning and operations platform covering Territory Alignment, Call Planning, Incentive Compensation and Field Reporting. It is built on the platform and integrates natively with Veeva CRM.

    As part of the transformation, Boehringer Ingelheim expects Axtria SalesIQ to deliver:

    • A scalable, enterprise-grade incentive compensation platform
    • A global solution that drives standardization across markets
    • Flexibility to work with localized data, currencies, credits and languages
    • Agility to adapt and grow with evolving business needs
    • A reduction in administration errors, often caused by spreadsheets and manual processes
    • Improvements in controls and transparency across business processes

    “We are excited to be partnering with Boehringer Ingelheim on this strategic initiative” said Jassi Chadha, Founder and CEO of Axtria. “This is a testament to the impact that our cloud solutions have on Commercial Operations processes. We look forward to delivering on the vision, improving field force effectiveness and incentivizing the right behaviors across the globe.”

    To learn more about Axtria and their cloud solutions, please visit

    Learn More linkClick Here To Learn More About Axtria Incentive Compensation Benchmarking Study – 2020 Results

    About Boehringer Ingelheim

    Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

    Contact Information

    Neha Garg
    Axtria, Inc.

    About Axtria

    Axtria is a global provider of award-winning cloud software and data analytics to the life sciences industry. Axtria’s solutions are used to digitally transform the entire product commercialization process, supporting RWE/HEOR, medical affairs, pricing and market access, product launch and post-launch, and marketing and sales operations to drive growth and improve healthcare outcomes for patients. Our focus is on delivering solutions that help pharmaceutical, medical device, and diagnostics companies complete the journey from data to insights to action and get superior returns from their investments. As a participant of the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption and taking actions that advance societal goals. For more information, visit

    Connect with Axtria on: